TY - JOUR
T1 - A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination
T2 - findings from 33 hepatitis elimination profiles
AU - Hiebert-Suwondo, Lindsey
AU - Manning, Jana
AU - Tohme, Rania A.
AU - Buti, Maria
AU - Kondili, Loreta A.
AU - Spearman, C. Wendy
AU - Prabdial-Sing, Nishi
AU - Turnier, Victoria
AU - Lazarus, Jeffrey V.
AU - Waked, Imam
AU - Ward, John W.
AU - Miranda, Angelica
AU - Sugiyama, Aya
AU - Hajarizadeh, Behzad
AU - Varaldo, Carlos
AU - Thomas, Caroline
AU - Muñoz, Chris
AU - Leeman, David
AU - Dore, Gregory
AU - Desalegn, Hailemicahel
AU - Aberra, Hanna
AU - Cheinquer, Hugo
AU - Qureshi, Huma
AU - Ivanchuk, Irina
AU - Grebely, Jason
AU - García-Samaniego, Javier
AU - Tanaka, Junko
AU - Tint, Khin San
AU - Poovorawan, Kittiyod
AU - De Feo, María Eugenia
AU - Sonderup, Mark
AU - Aleksandrova, Maryna
AU - Ali, Mohammad
AU - Hassany, Mohamed
AU - Marinho, Rui
AU - Hamid, Saeed
AU - Punpetch, Samart
AU - Naing, Thandar Su
AU - Tanaka-Kumadai, Yasu
AU - Lim, Young Suk
AU - Nartey, Yvonne
N1 - Publisher Copyright:
© 2025 Elsevier Ltd
PY - 2025/7
Y1 - 2025/7
N2 - The Coaltion for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, policy, and programme development the elimination of viral hepatitis. Profiles from 33 countries and territories show progress, towards elimination of hepatitis B with 24 (73%) of them meeting the 2025 WHO interim target of 0·5% or less HBsAg prevalence in children younger than 5 years. 22 (67%) of countries and territories profiled have policies for universal hepatitis B birth-dose vaccination of newborns. Access to hepatitis B testing and treatment, including removing HBsAg screening and hepatitis B treatment patient co-payments and simplifying treatment algorithms, remains suboptimal, especially in low-income and middle-income countries and territories. Of the seven profiled countries and territories meeting the 60% WHO 2025 diagnosis coverage target, all but one (Rwanda) is a high-income country or territory. No country or territory has met the WHO 2025 treatment target of at least 50% of people living with hepatitis B receiving treatment. The profiles guide national planning and identify priorities for resource mobilisation to further accelerate hepatitis B elimination.
AB - The Coaltion for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, policy, and programme development the elimination of viral hepatitis. Profiles from 33 countries and territories show progress, towards elimination of hepatitis B with 24 (73%) of them meeting the 2025 WHO interim target of 0·5% or less HBsAg prevalence in children younger than 5 years. 22 (67%) of countries and territories profiled have policies for universal hepatitis B birth-dose vaccination of newborns. Access to hepatitis B testing and treatment, including removing HBsAg screening and hepatitis B treatment patient co-payments and simplifying treatment algorithms, remains suboptimal, especially in low-income and middle-income countries and territories. Of the seven profiled countries and territories meeting the 60% WHO 2025 diagnosis coverage target, all but one (Rwanda) is a high-income country or territory. No country or territory has met the WHO 2025 treatment target of at least 50% of people living with hepatitis B receiving treatment. The profiles guide national planning and identify priorities for resource mobilisation to further accelerate hepatitis B elimination.
UR - http://www.scopus.com/inward/record.url?scp=105005654342&partnerID=8YFLogxK
U2 - 10.1016/S2468-1253(25)00069-X
DO - 10.1016/S2468-1253(25)00069-X
M3 - Review article
AN - SCOPUS:105005654342
SN - 2468-1253
VL - 10
SP - 671
EP - 684
JO - The Lancet Gastroenterology and Hepatology
JF - The Lancet Gastroenterology and Hepatology
IS - 7
ER -
